PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.
Memory B and plasma cells (PCs) are generated in the germinal center (GC). Because follicular helper T cells (T(FH) cells) have high expression of the immunoinhibitory receptor PD-1, we investigated the role of PD-1 signaling in the humoral response. We found that the PD-1 ligands PD-L1 and PD-L2 were upregulated on GC B cells. Mice deficient in PD-L2 (Pdcd1lg2(-/-)), PD-L1 and PD-L2 (Cd274(-/-)Pdcd1lg2(-/-)) or PD-1 (Pdcd1(-/-)) had fewer long-lived PCs. The mechanism involved more GC cell death and less T(FH) cell cytokine production in the absence of PD-1; the effect was selective, as remaining PCs had greater affinity for antigen. PD-1 expression on T cells and PD-L2 expression on B cells controlled T(FH) cell and PC numbers. Thus, PD-1 regulates selection and survival in the GC, affecting the quantity and quality of long-lived PCs.
Good-Jacobson
Kim L
KL
Department of Laboratory Medicine, Yale University, New Haven, Connecticut, USA.
Szumilas
Courtney G
CG
Chen
Lieping
L
Sharpe
Arlene H
AH
Tomayko
Mary M
MM
Shlomchik
Mark J
MJ
D000818:Animals; D000954:Antigens, Surface / Q000235:genetics / Q000378:metabolism*; D051017:Apoptosis Regulatory Proteins / Q000235:genetics / Q000378:metabolism*; D001402:B-Lymphocytes / Q000166:cytology* / Q000276:immunology; D002454:Cell Differentiation; D002470:Cell Survival; D018858:Germinal Center / Q000166:cytology*; D051379:Mice; D018345:Mice, Knockout; D010950:Plasma Cells / Q000166:cytology*; D061026:Programmed Cell Death 1 Receptor
D000954:Antigens, Surface; D051017:Apoptosis Regulatory Proteins; C491383:Pdcd1 protein, mouse; D061026:Programmed Cell Death 1 Receptor
J Exp Med. 2010 Feb 15;207(2):365-78
20142430
J Exp Med. 2006 Apr 17;203(4):883-95
16606670
J Immunol. 1995 Jul 15;155(2):556-67
7541819
Science. 2002 Nov 22;298(5598):1630-4
12446913
Nat Immunol. 2004 Jan;5(1):55-63
14647274
Science. 2007 Jan 26;315(5811):528-31
17185562
J Exp Med. 1996 May 1;183(5):2303-12
8642339
Int Immunol. 1993 Jun;5(6):647-56
8347558
Nat Immunol. 2009 Jan;10(1):29-37
19043418
Int Immunol. 1998 Oct;10(10):1563-72
9796923
J Exp Med. 2003 Jul 7;198(1):31-8
12847135
Int Immunol. 1993 Oct;5(10):1329-41
8268138
Eur J Immunol. 1991 Dec;21(12):2951-62
1748148
J Exp Med. 1999 Aug 2;190(3):399-410
10430628
Immunity. 1997 Mar;6(3):225-33
9075923
J Immunol. 2009 Jan 15;182(2):890-901
19124732
J Exp Med. 2000 Oct 2;192(7):931-42
11015435
J Immunol. 2002 Nov 15;169(10):5538-45
12421930
J Immunol. 2008 Nov 15;181(10):6738-46
18981091
Eur J Immunol. 2007 Sep;37(9):2405-10
17683117
J Exp Med. 2007 Sep 3;204(9):2103-14
17698588
Nature. 2001 Jul 19;412(6844):341-6
11460166
Immunity. 2009 Mar 20;30(3):324-35
19303387
Science. 1993 Feb 12;259(5097):990-3
7679801
J Immunol. 2009 Dec 1;183(11):7314-25
19917681
J Exp Med. 2000 Oct 2;192(7):1027-34
11015443
J Exp Med. 1995 Aug 1;182(2):541-8
7629511
Int Immunol. 2008 May;20(5):683-94
18397909
Immunity. 2007 Jul;27(1):111-22
17629517
J Immunol. 2007 Oct 15;179(8):5064-70
17911591
J Exp Med. 2010 Jan 18;207(1):155-71
20048285
J Exp Med. 2008 Mar 17;205(3):543-55
18332181
J Exp Med. 2010 Feb 15;207(2):353-63
20142429
J Exp Med. 1998 Mar 16;187(6):885-95
9500791
Int Immunol. 2005 May;17(5):581-9
15824068
J Exp Med. 2005 Feb 21;201(4):545-54
15710653
J Immunol. 2008 Feb 1;180(3):1309-15
18209024
J Exp Med. 2009 Mar 16;206(3):561-76
19221396
Nature. 1991 Dec 5;354(6352):389-92
1956400
Immunol Cell Biol. 1998 Oct;76(5):448-53
9797466
Nat Immunol. 2007 Mar;8(3):239-45
17304234
Immunity. 2001 Feb;14(2):181-92
11239450
Nat Immunol. 2001 Mar;2(3):261-8
11224527
J Exp Med. 2009 Dec 21;206(13):3015-29
20008522
J Immunol. 2008 Jul 1;181(1):27-38
18566367
J Immunol. 2004 Jul 1;173(1):68-78
15210760
J Exp Med. 2009 May 11;206(5):1001-7
19380638
J Exp Med. 1996 Oct 1;184(4):1269-78
8879198
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2639-44
12604779
J Exp Med. 1993 Oct 1;178(4):1293-307
8376935